NRXP – nrx pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
NRx Pharmaceuticals (NASDAQ:NRXP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
NRx Pharmaceuticals (NASDAQ:NRXP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion [Yahoo! Finance]
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Form EFFECT NRX Pharmaceuticals,
Form 424B3 NRX Pharmaceuticals,
Form S-3/A NRX Pharmaceuticals,
Form 8-K NRX Pharmaceuticals, For: Nov 20
Form 8-K/A NRX Pharmaceuticals, For: Sep 08
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.